Human neuroblastoma (SH-SY5Y) cells are highly sensitive to the lysosomotropic aldehyde 3-aminopropanal.
3-Aminopropanal (3-AP), a degradation product of polyamines such as spermine, spermidine and putrescine, is a lysosomotropic small aldehyde that causes apoptosis or necrosis of most cells in culture, apparently by inducing moderate or extensive lysosomal rupture, respectively, and secondary mitochondrial changes. Here, using the human neuroblastoma SH-SY5Y cell line, we found simultaneous occurrence of apoptotic and necrotic cell death when cultures were exposed to 3-AP in concentrations that usually are either nontoxic, or only cause apoptosis. At 30 mM, but not at 10 mM, the lysosomotropic base and proton acceptor NH3 completely blocked the toxic effect of 3-AP, proving that 3-AP is lysosomotropic and suggesting that the lysosomal membrane proton pump of neuroblastoma cells is highly effective, creating a lower than normal lysosomal pH and, thus, extensive intralysosomal accumulation of lysosomotropic drugs. A wave of internal oxidative stress, secondary to changes in mitochondrial membrane potential, followed and gave rise to further lysosomal rupture. The preincubation of cells for 24 h with a chain-breaking free radical-scavenger, alpha-tocopherol, before exposure to 3-AP, significantly delayed both the wave of oxidative stress and the secondary lysosomal rupture, while it did not interfere with the early 3-AP-mediated phase of lysosomal break. Obviously, the reported oxidative stress and apoptosis/necrosis are consequences of lysosomal rupture with ensuing release of lysosomal enzymes resulting in direct/indirect effects on mitochondrial permeability, membrane potential, and electron transport. The induced oxidative stress seems to act as an amplifying loop causing further lysosomal break that can be partially prevented by alpha-tocopherol. Perhaps secondary brain damage during a critical post injury period can be prevented by the use of drugs that temporarily raise lysosomal pH, inactivate intralysosomal 3-AP, or stabilize lysosomal membranes against oxidative stress.
Yu
Zhengquan
Z
Divisions of Pathology II, Faculty of Health Sciences, Linköping University, Linköping, Sweden.
Li
Wei
W
Hillman
Jan
J
Brunk
Ulf T
UT
D000447:Aldehydes / Q000494:pharmacology*; D000643:Ammonium Chloride / Q000494:pharmacology; D000704:Analysis of Variance; D017304:Annexin A5; D017209:Apoptosis; D045744:Cell Line, Tumor; D002470:Cell Survival / Q000187:drug effects; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D015853:Cysteine Proteinase Inhibitors / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004563:Electrochemistry / Q000379:methods; D005434:Flow Cytometry / Q000379:methods; D005452:Fluoresceins; D005978:Glutathione / Q000378:metabolism; D006801:Humans; D007930:Leucine / Q000031:analogs & derivatives / Q000494:pharmacology; D008247:Lysosomes / Q000187:drug effects; D008928:Mitochondria / Q000187:drug effects; D009336:Necrosis; D009447:Neuroblastoma; D010436:Pepstatins / Q000494:pharmacology; D011437:Propylamines / Q000494:pharmacology*; D011480:Protease Inhibitors / Q000494:pharmacology; D017382:Reactive Oxygen Species / Q000378:metabolism; D012235:Rhodamines; D013997:Time Factors; D024502:alpha-Tocopherol / Q000494:pharmacology
D000447:Aldehydes; D017304:Annexin A5; D015853:Cysteine Proteinase Inhibitors; D005452:Fluoresceins; D010436:Pepstatins; D011437:Propylamines; D011480:Protease Inhibitors; D017382:Reactive Oxygen Species; D012235:Rhodamines; D000643:Ammonium Chloride; C029569:diacetyldichlorofluorescein; C005358:tetramethylrhodamine; D005978:Glutathione; D007930:Leucine; D024502:alpha-Tocopherol; C108192:aloxistatin; C050862:3-aminopropionaldehyde; C031375:pepstatin